权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Molecular mechanisms of age-related lymphatic dysfunction

年龄相关淋巴功能障碍的分子机制

基本信息

批准号：
10665795
负责人：
Babak J Mehrara
金额：
$ 22.13万
依托单位：
SLOAN-KETTERING INST CAN RESEARCH
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-07-15 至 2025-03-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10665795
关键词：
Affect Aging Alzheimer&apos s Disease Anatomy Animals Antibodies Apoptosis Arthritis Autoimmunity Binding Blood Blood Vessels Cardiovascular Diseases Cell Differentiation process Cell Proliferation Cell Separation Cell surface Central Nervous System Cholesterol Homeostasis Chronic Clinical Cytoprotection Elderly Endothelial Cells Event Fatty Acids Female Functional disorder Future Goals Growth Factor Histamine Release Histologic Homologous Gene Immune response Impairment In Vitro Infection Inflammation Injury Intestines Knockout Mice Ligands Lymphatic Lymphatic Endothelial Cells Lymphatic System Lymphatic clearance Lymphatic function Lymphedema Mediating Metabolic syndrome Molecular Mus Muscle Cells Obesity PIK3CG gene PTEN gene Pathologic Pathway interactions Phenotype Phosphorylation Physiological Play Proliferating Pump Reactive Nitrogen Species Receptor Protein-Tyrosine Kinases Recombinant Vascular Endothelial Growth Factor Research Research Design Resolution Role Signal Transduction Skin Tamoxifen Testing Tissues Transgenic Mice Vascular Endothelial Growth Factor C Vascular Endothelial Growth Factor Receptor-3 adaptive immune response age effect age related body system conditional knockout density endothelial dysfunction experimental study improved in vivo innovation lymphatic development lymphatic dysfunction lymphatic malformations lymphatic pump lymphatic vessel macromolecule male mast cell neutralizing antibody nitrosative stress novel older patient promoter receptor receptor binding response tumor

项目摘要

PROJECT SUMMARY/ABSTRACT Aging results in impaired lymphatic function in a variety of organ systems. This is important because the lymphatic system has many physiologic functions, and lymphatic abnormalities are implicated in many pathologic conditions that affect the elderly. However, while it is clear that aging impairs lymphatic function, the cellular mechanisms that regulate this response remain largely unknown. In addition, the effects of aging on lymphatic endothelial cell (LEC) response to vascular endothelial growth factor C (VEGFC), downstream pathways involving Pi3k and Akt signaling, and interactions with lymphatic muscle cells have not been analyzed. In previous and preliminary studies, we have found that chronic inflammation in a variety of settings, including obesity, lymphedema, and aging, results in decreased intracellular LEC Pi3K/Akt signaling. This is important since LEC Pi3K/Akt signaling is a key regulator of LEC proliferation, differentiation, and function. These findings are consistent with previous studies demonstrating that abnormalities in Pi3k/Akt signaling also contribute to age-related blood endothelial dysfunction. In this proposal, we aim to test the hypothesis that decreased LEC intracellular Pi3k/Akt signaling plays a causal role in age-related lymphatic dysfunction. Our study is innovative because previous studies have been largely observational and have not analyzed lymphangiogenic signaling in aging. We have also developed novel transgenic mice that enable us to selectively analyze the effects of changes in LEC intracellular Pi3k/Akt signaling, thus avoiding the limitations of previous studies that have relied on the systemic administration of recombinant VEGFC or VEGF-R3 antibodies. Using two aims, we will determine how aging changes LEC Pi3k/Akt signaling in different tissues and how these changes correlate with lymphatic function. These studies will help us determine how LECs respond to VEGFC in aging and how these changes modulate response to inflammation and nitrosative stress. In other studies, we will determine if inhibition of intracellular LEC Pi3k/Akt signaling in young mice can recapitulate the lymphatic phenotype of old mice. Finally, we will determine if increased LEC Pi3k/Akt signaling can improve lymphatic function in elderly mice. At the conclusion of our proposed research, we will have a detailed understanding of the cellular mechanisms that contribute to age-related lymphatic dysfunction. This understanding will provide the basis for future studies designed to improve lymphatic function.

项目总结/文摘